History of glucagon-like peptide-1 receptor agonists

• GLP-1RA development traces a century of translational progress from gut hormones to multi-agonist therapeutics. • Rational protein engineering and delivery innovations transformed incretin biology into global metabolic therapeutics. • Modern dual and triple agonists achieve surgical-level metabolic benefits, redefining diabetes and obesity care.